Higher Adherence to Treatment with Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin because of Side Effects in Cancer-Associated Venous Thromboembolism
- Van Der Wall, S.J.
- Klok, F.A.
- Den Exter, P.L.
- Barrios, D.
- Morillo, R.
- Cannegieter, S.C.
- Jimenez, D.
- Huisman, M.V.
Revue:
HemaSphere
ISSN: 2572-9241
Année de publication: 2018
Volumen: 2
Número: 1
Type: Article
